In this study, high levels of MMP-9, PTGDS, SLC26A8, and CD160 and reduced levels of TLR5 protein in patients with IBD (identified using WB and immunofluorescence analysis) suggest that these are clinically significant in IBD. This evidence concerns the gene PTGDS and inflammatory bowel disease.